NAS Healthcare » Editor

Office 0203 509 8409
Mobile 07776 181227

Is there a case for indication-based drug pricing?

How is the ‘infodemic’ of scientific publications affecting quality?

Payer Research – Case Study on Market Access for Epilepsy Medical Device

European clinical trial guidance during the COVID-19 pandemic

German and French regulators recognise benefits of RWE

Rare Disease Day 2020: Orphan drugs still face challenges to market access

Recent Case Studies

Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review
Have we learned the lessons that coronavirus has offered us?
Will certain treatment types become more relevant with access to healthcare restricted because of the pandemic?
In the race for a vaccine, has the importance of effective COVID-19 treatment options been overlooked?
Reflections on 2020: finding positivity in a time of crisis

Contact

> Email
> Mobile 07776 181227
> Office 0203 509 8409